Gilead has a plan to make remdesivir more effective against coronavirus

[Chris Smith]

• Experimental coronavirus drug remdesivir is effective in mild to moderate COVID-19 cases, according to recent research.
• Remdesivir can’t prevent complications or reduce mortality, but Gilead thinks that administering the therapy earlier to confirmed patients could improve the results.
• The drugmaker will use remdesivir inside a nebulizer in a clinical test to speed up access to treatment. Currently, the drug is administered intravenously.

Remdesivir is one of the two drugs that has proven to be effective against the novel coronavirus — the other is dexamethasone. Both of them, however, cater to particular types of COVID-19 patients. Dexamethasone works in severe cases when the immune response needs to be mitigated. Remdesivir can reduce the time to recover for patients who exhibit mild to moderate symptoms, but the drug can’t prevent complications or death.

Gilead Sciences, the company that developed the drug, is currently ramping up supply of remdesivir. Additionally, Gilead is studying new ways to increase the effectiveness of remdesivir, and one of them involves turning the intravenous drug into a substance that can be used with a nebulizer.

Continue reading...

Today's Top Deals

1. Today’s top deals: 3M N95 face masks, Purell in stock, Clorox wipes, $24 Roku player, Samsung QLED TVs, more
2. Purell is in stock at Amazon, and so is hand sanitizer that’s even stronger
3. Amazon’s Big Style Sale: All the best deals you can get on Tuesday

Trending Right Now:

1. Trump says new stimulus checks are finally on the way – here’s everything you need to know
2. If you’re using one of these hand sanitizers, get rid of it immediately
3. Some people are getting new stimulus checks up to $4,000/month right now

Gilead has a plan to make remdesivir more effective against coronavirus originally appeared on BGR.com on Tue, 23 Jun 2020 at 17:23:02 EDT. Please see our terms for use of feeds.

Via BRG - Boy Genius Report